Calbindin-D(28k) controls Ca(2+) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines - PubMed (original) (raw)
. 1999 Nov 26;274(48):34343-9.
doi: 10.1074/jbc.274.48.34343.
Collaborators, Affiliations
- PMID: 10567411
- DOI: 10.1074/jbc.274.48.34343
Free article
Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines
K Sooy et al. J Biol Chem. 1999.
Free article
Abstract
The role of the calcium-binding protein, calbindin-D(28k) in potassium/depolarization-stimulated increases in the cytosolic free Ca(2+) concentration ([Ca(2+)](i)) and insulin release was investigated in pancreatic islets from calbindin-D(28k) nullmutant mice (knockouts; KO) or wild type mice and beta cell lines stably transfected and overexpressing calbindin. Using single islets from KO mice and stimulation with 45 mM KCl, the peak of [Ca(2+)](i) was 3.5-fold greater in islets from KO mice compared with wild type islets (p < 0.01) and [Ca(2+)](i) remained higher during the plateau phase. In addition to the increase in [Ca(2+)](i) in response to KCl there was also a significant increase in insulin release in islets isolated from KO mice. Evidence for modulation by calbindin of [Ca(2+)](i) and insulin release was also noted using beta cell lines. Rat calbindin was stably expressed in betaTC-3 and betaHC-13 cells. In response to depolarizing concentrations of K(+), insulin release was decreased by 45-47% in calbindin expressing betaTC cells and was decreased by 70-80% in calbindin expressing betaHC cells compared with insulin release from vector transfected betaTC or betaHC cells (p < 0.01). In addition, the K(+)-stimulated intracellular calcium peak was markedly inhibited in calbindin expressing betaHC cells compared with vector transfected cells (225 nM versus 1,100 nM, respectively). Buffering of the depolarization-induced rise in [Ca(2+)](i) was also observed in calbindin expressing betaTC cells. In summary, our findings, using both isolated islets from calbindin-D(28k) KO mice and beta cell lines, establish a role for calbindin in the modulation of depolarization-stimulated insulin release and suggest that calbindin can control the rate of insulin release via regulation of [Ca(2+)](i).
Similar articles
- Intracellular calcium ion response to glucose in beta-cells of calbindin-D28k nullmutant mice and in betaHC13 cells overexpressing calbindin-D28k.
Parkash J, Chaudhry MA, Amer AS, Christakos S, Rhoten WB. Parkash J, et al. Endocrine. 2002 Aug;18(3):221-9. doi: 10.1385/ENDO🔞3:221. Endocrine. 2002. PMID: 12450313 - Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis.
Rabinovitch A, Suarez-Pinzon WL, Sooy K, Strynadka K, Christakos S. Rabinovitch A, et al. Endocrinology. 2001 Aug;142(8):3649-55. doi: 10.1210/endo.142.8.8334. Endocrinology. 2001. PMID: 11459814 - Calbindin-D28k decreases L-type calcium channel activity and modulates intracellular calcium homeostasis in response to K+ depolarization in a rat beta cell line RINr1046-38.
Lee D, Obukhov AG, Shen Q, Liu Y, Dhawan P, Nowycky MC, Christakos S. Lee D, et al. Cell Calcium. 2006 Jun;39(6):475-485. doi: 10.1016/j.ceca.2006.01.010. Epub 2006 Mar 13. Cell Calcium. 2006. PMID: 16530828 - Calmodulin and calbindin in pancreatic islet cells.
Malaisse WJ, Blachier F, Pochet R, Manuel y Keenoy B, Sener A. Malaisse WJ, et al. Adv Exp Med Biol. 1990;269:127-33. doi: 10.1007/978-1-4684-5754-4_20. Adv Exp Med Biol. 1990. PMID: 2191550 Review. - Vitamin D target proteins: function and regulation.
Christakos S, Barletta F, Huening M, Dhawan P, Liu Y, Porta A, Peng X. Christakos S, et al. J Cell Biochem. 2003 Feb 1;88(2):238-44. doi: 10.1002/jcb.10349. J Cell Biochem. 2003. PMID: 12520521 Review.
Cited by
- Role of Divalent Cations in Infections in Host-Pathogen Interaction.
D'Elia JA, Weinrauch LA. D'Elia JA, et al. Int J Mol Sci. 2024 Sep 10;25(18):9775. doi: 10.3390/ijms25189775. Int J Mol Sci. 2024. PMID: 39337264 Free PMC article. Review. - Vitamin D efficacy in type 1 and type 2 diabetes.
Kawahara T, Okada Y, Tanaka Y. Kawahara T, et al. J Bone Miner Metab. 2024 Jul;42(4):438-446. doi: 10.1007/s00774-024-01509-3. Epub 2024 Apr 25. J Bone Miner Metab. 2024. PMID: 38664254 Review. - Optimal vitamin D supplement dosage for improving insulin resistance in children and adolescents with overweight/obesity: a systematic review and network meta-analysis.
Zhu L, Li S, Zhong L, Xu S, Zhu H. Zhu L, et al. Eur J Nutr. 2024 Apr;63(3):763-775. doi: 10.1007/s00394-023-03301-x. Epub 2023 Dec 30. Eur J Nutr. 2024. PMID: 38160221 Free PMC article. - Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin.
Alshahrani A, Aljada A, Masood A, Mujammami M, Alfadda AA, Musambil M, Alanazi IO, Al Dubayee M, Abdel Rahman AM, Benabdelkamel H. Alshahrani A, et al. Pharmaceuticals (Basel). 2023 Sep 23;16(10):1345. doi: 10.3390/ph16101345. Pharmaceuticals (Basel). 2023. PMID: 37895816 Free PMC article. - The Association between Vitamin D Hypovitaminosis and Cardiovascular Disease Risk in Saudi Diabetic Patients Type II.
Alrefai AA, Elsalamony E, Fatani SH, Kasemy ZA, Fatani A, Mohamed Kamel HF. Alrefai AA, et al. Biochem Res Int. 2022 Sep 23;2022:6097864. doi: 10.1155/2022/6097864. eCollection 2022. Biochem Res Int. 2022. PMID: 36193546 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous